-
Psyence, Filament Strike Magic Mushroom Product Licensing Agreement: What You Need To Know
Tuesday, April 19, 2022 - 11:50am | 219Psyence Group (OTCQB: PSYGF) and Filament Health Corp. (OTCQB: FLHLF) announced the signing of a licensing agreement: Filament is to license its proprietary psilocybin derived drug, PEX010, and the associated IP to Psyence for use in its upcoming clinical trials. Thanks to this license,...
-
Psyched: Cybin Debuts On NYSE, Nonprofits In Psychedelics Space Reach New Milestones, Filament Receives Psilocybin Patent
Tuesday, August 10, 2021 - 8:56am | 1191Cybin Debuts On The NYSE Last week, Cybin (NYSE: CYBN) began listing its stock on the New York Stock Exchange. The company is the first in the sector to enter the NYSE, following a trend of five psychedelics companies to debut on the Nasdaq since the beginning of the year. “This validation by...